tadalafil vs pt-141
tadalafil (S-tier) vs pt-141 (A-tier). mechanism, trials, evidence boundaries, dosing literature. side-by-side reference.
tadalafil · tier S
this is cialis, the erection pill. the same molecule does three jobs. it helps men with erectile dysfunction get an erection, it eases the urinary symptoms of an enlarged prostate, and at 40 mg, under the name adcirca, it treats high blood pressure in the arteries of the lungs. a pde5 inhibitor with a 17.5-hour mean half-life, two decades of approved human trials, and a research channel selling two other molecules under its name.
it is cialis, the erection pill. it is approved for erection problems, for the urinary symptoms of an enlarged prostate, and at the higher 40 mg dose, as adcirca, for high blood pressure in the arteries of the lungs. the approved evidence is enormous and mostly positive. the trouble starts at the label on the research vial, where the same word covers two other molecules.
9,000+ men dosed in trials · half-life 17.5 h mean terminal (Cialis label); median Tmax 2 h, range 30 min to 6 h · libido
pt-141 · tier A
the FDA-approved sex peptide for acquired generalized HSDD in premenopausal women. off-label male use is a separate evidence lane.
FDA-approved as Vyleesi for HSDD in premenopausal women. the louder cultural use case (male PDE5 non-responders) is off-label and being formally tested.
FDA '19 Vyleesi · HSDD · half-life ~2 hours (peak central effect 45-60 min) · libido
at a glance
reptides grades the research record and cites the literature behind every call. research reference only; not medical advice.